Financhill
Back

Rise Gold Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
41

RYES
Rise Gold

Last Price:
$0.09
Seasonality Move:
-14.99%
Buy
52

SRPT
Sarepta Therapeutics

Last Price:
$51.00
Seasonality Move:
12.51%
Sell
41
Rise Gold (RYES) is a Sell

Is Rise Gold a Buy, Sell or Hold?

  • The current Rise Gold [RYES] share price is $0.09. The Score for RYES is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • RYES is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $51.03. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RYES Stock Price Chart

What is Rise Gold's stock price today?

  • The Rise Gold share price today is $0.09
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYES is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $51.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.

RYES Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 58.76 Buy
Chaikin Money Flow: 1209 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.05 - 0.09) Buy
Bollinger Bands (100): (0.07 - 0.09) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -12.25 Sell
Relative Strength Index (14 RSI): 26.54 Sell
Chaikin Money Flow: 1747021 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (55.57 - 90.55) Sell
Bollinger Bands (100): (83.88 - 128.16) Sell

RYES Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.08 Buy
20-day SMA: 0.08 Buy
50-day SMA: 0.07 Buy
200-day SMA: 0.11 Sell
8-day EMA: 0.08 Buy
20-day EMA: 0.07 Buy
50-day EMA: 0.07 Buy
200-day EMA: 0.1 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.28 Sell
20-day SMA: 66.37 Sell
50-day SMA: 91.18 Sell
200-day SMA: 120.65 Sell
8-day EMA: 55.11 Sell
20-day EMA: 66.27 Sell
50-day EMA: 84.86 Sell
200-day EMA: 110.43 Sell

Rise Gold Earnings Growth & RYES Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.27 per share, a decrease next quarter of $0.11 per share, an increase this year of $3.98 per share, and an increase next year of $6.27 per share.

Rise Gold Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):